Pubblicazioni

Autologous stem cell transplantation in favorable-risk acute myeloid leukemia: single-center experience and current challenges

2022 - INTERNATIONAL JOURNAL OF HEMATOLOGY

Autologous stem cell transplantation in favorable-risk acute myeloid leukemia: single-center experience and current challenges

2022 - INTERNATIONAL JOURNAL OF HEMATOLOGY

Capria, Saveria; Trisolini, Silvia Maria; Diverio, Daniela; Minotti, Clara; Breccia, Massimo; Cartoni, Claudio; Carmini, Daniela; Gozzer, Maria; La Rocca, Ursula; Shafii Bafti, Mahnaz; Martelli, Maurizio

Azacitidine to Consolidate and Deepen the Therapeutic Response Achieved by Intensive Induction Treatment in a Young Patient Affected by NPM1mut-AML Who Has Become Ineligible for High-Dose Consolidation

2022 - CHEMOTHERAPY

Cenfra, Natalia; Lapietra, Gianfranco; Perrone, Salvatore; Voso, Maria Teresa; Divona, Mariadomenica; Mecarocci, Sergio; La Barbera, Elettra Ortu; Cimino, Giuseppe

CyBorD-DARA in Newly Diagnosed Transplant-Eligible Multiple Myeloma: Results from the 16-BCNI-001/CTRIAL-IE 16-02 Study Show High Rates of MRD Negativity at End of Treatment

2022 - CLINICAL LYMPHOMA MYELOMA & LEUKEMIA

Swan, D; Henderson, R; Mcellistrim, C; Naicker, S D; Quinn, J; Cahill, M R; Mykytiv, V; Lenihan, E; Mulvaney, E; Nolan, M; Parker, I; Natoni, A; Lynch, K; Ryan, A E; Szegezdi, E; Krawczyk, J; Murphy, P; O'Dwyer, M

Does MRD have a role in the management of iNHL ?

2021 - HEMATOLOGY

Del Giudice, I.; Starza, I. D.; Foa, R.

Response-Adapted Postinduction Strategy in Patients With Advanced-Stage Follicular Lymphoma: The FOLL12 Study

2021 - JOURNAL OF CLINICAL ONCOLOGY

Luminari, S.; Manni, M.; Galimberti, S.; Versari, A.; Tucci, A.; Boccomini, C.; Farina, L.; Olivieri, J.; Marcheselli, L.; Guerra, L.; Ferrero, S.; Arcaini, L.; Cavallo, F.; Kovalchuk, S.; Skrypets, T.; Del Giudice, I.; Chauvie, S.; Patti, C.; Stelitano, C.; Ricci, F.; Pinto, A.; Margiotta Casaluci, G.; Zilioli, V. R.; Merli, A.; Ladetto, M.; Bolis, S.; Pavone, V.; Chiarenza, A.; Arcari, A.; Anastasia, A.; Dondi, A.; Mannina, D.; Federico, M.

Droplet Digital PCR Improves IG-/TR-based MRD Risk Definition in Childhood B-cell Precursor Acute Lymphoblastic Leukemia

2021 - HEMASPHERE

Della Starza, Irene; Nunes, Vittorio; Lovisa, Federica; Silvestri, Daniela; Cavalli, Marzia; Garofalo, Andrea; Campeggio, Mimma; De Novi, Lucia Anna; Soscia, Roberta; Oggioni, Carlotta; Mussolin, Lara; Biondi, Andrea; Guarini, Anna; Valsecchi, Maria Grazia; Conter, Valentino; Biffi, Alessandra; Basso, Giuseppe; FoÃ , Robin; Cazzaniga, Giovanni

High rate of MRD-responses in young and fit patients with IGHV mutated chronic lymphocytic leukemia treated with front-line fludarabine, cyclophosphamide, and intensified dose of ofatumumab (FCO2)

2020 - HAEMATOLOGICA

Mauro, F. R.; Molica, S.; Soddu, S.; Ilariucci, F.; Coscia, M.; Zaja, F.; Angelucci, E.; Re, F.; Liberati, A. M.; Tedeschi, A.; Reda, G.; Pietrasanta, D.; Gozzetti, A.; Battistini, R.; Del Poeta, G.; Musolino, C.; Nanni, M.; Piciocchi, A.; Vignetti, M.; Neri, A.; Albano, F.; Cuneo, A.; Giudice, I. D.; Starza, I. D.; de Propris, M. S.; Raponi, S.; Guarini, A. R.; Foa, R.

Cord blood transplantation for acute leukemia

2020 - EXPERT OPINION ON BIOLOGICAL THERAPY

Algeri, M.; Gaspari, S.; Locatelli, F.

Cord blood transplantation for acute leukemia

2020 - EXPERT OPINION ON BIOLOGICAL THERAPY

Algeri, M.; Gaspari, S.; Locatelli, F.

CPX-351 treatment in secondary acute myeloblastic leukemia is effective and improves the feasibility of allogeneic stem cell transplantation: results of the Italian compassionate use program

2020 - BLOOD CANCER JOURNAL

Tafuri, Agostino

Blinatumomab for Acute Lymphoblastic Leukemia: The First Bispecific T-Cell Engager Antibody to Be Approved by the EMA for Minimal Residual Disease

2020 - THE ONCOLOGIST

Ali, S.; Moreau, A.; Melchiorri, D.; Camarero, J.; Josephson, F.; Olimpier, O.; Bergh, J.; Karres, D.; Tzogani, K.; Gisselbrecht, C.; Pignatti, F.

Minimal residual disease level predicts outcome in adults with Ph-negative B-precursor acute lymphoblastic leukemia

2019 - HEMATOLOGY

Gokbuget, N.; Dombret, H.; Giebel, S.; Bruggemann, M.; Doubek, M.; Foa, R.; Hoelzer, D.; Kim, C.; Martinelli, G.; Parovichnikova, E.; Rambaldi, A.; Ribera, J. -M.; Schoonen, M.; Stieglmaier, J. M.; Zugmaier, G.; Bassan, R.

Minimal Residual Disease in Chronic Lymphocytic Leukemia: A New Goal?

2019 - FRONTIERS IN ONCOLOGY

Del Giudice, I.; Raponi, S.; Della Starza, I.; De Propris, M. S.; Cavalli, M.; De Novi, L. A.; Cappelli, L. V.; Ilari, C.; Cafforio, L.; Guarini, A.; Foa, R.

Ficoll-hypaque separation vs whole blood lysis: Comparison of efficiency and impact on minimal residual disease analysis

2018 - INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY

Genuardi, E.; Barbero, D.; Dogliotti, I.; Mantoan, B.; Drandi, D.; Gambella, M.; Zaccaria, G. M.; Monitillo, L.; Della Starza, I.; Cavalli, M.; De Novi, L. A.; Ciabatti, E.; Grassi, S.; Gazzola, A.; Mannu, C.; Del Giudice, I.; Galimberti, S.; Agostinelli, C.; Piccaluga, P. P.; Ladetto, M.; Ferrero, S.

Comparative analysis between RQ-PCR and digital droplet PCR of BCL2/IGH gene rearrangement in the peripheral blood and bone marrow of early stage follicular lymphoma

2017 - BRITISH JOURNAL OF HAEMATOLOGY

Cavalli, M.; De Novi, L. A.; Della Starza, I.; Cappelli, L. V.; Nunes, V.; Pulsoni, A.; Del Giudice, I.; Guarini, A.; Foa, R.

Protocol II vs protocol III given twice during reinduction therapy in children with medium-risk all

2017 - BLOOD

Locatelli, F.; Valsecchi, M. G.; Moricke, A.; Zimmermann, M.; Gruhn, B.; Biondi, A.; Kulozik, A. E.; Silvestri, D.; Bodmer, N.; Putti, M. C.; Burdach, S.; Micalizzi, C.; Teigler-Schlegel, A.; Ritter, J.; Pession, A.; Cario, G.; Bielack, S.; Basso, G.; Klingebiel, T.; Vinti, L.; Rizzari, C.; Attarbaschi, A.; Santoro, N.; Parasole, R.; Mann, G.; Karawajew, L.; Haas, O. A.; Conter, V.; Schrappe, M.

Characterization of children with flt3-itd acute myeloid leukemia. a report from the aieop aml-2002 study group

2017 - LEUKEMIA

Manara, E.; Basso, G.; Zampini, M.; Buldini, B.; Tregnago, C.; Rondelli, R.; Masetti, R.; Bisio, V.; Frison, M.; Polato, K.; Cazzaniga, G.; Menna, G.; Fagioli, F.; Merli, P.; Biondi, A.; Pession, A.; Locatelli, F.; Pigazzi, M.

Prognostic significance of flow-cytometry evaluation of minimal residual disease in children with acute myeloid leukaemia treated according to the aieop-aml 2002/01 study protocol

2017 - BRITISH JOURNAL OF HAEMATOLOGY

Buldini, B.; Rizzati, F.; Masetti, R.; Fagioli, F.; Menna, G.; Micalizzi, C.; Putti, M. C.; Rizzari, C.; Santoro, N.; Zecca, M.; Disaro, S.; Rondelli, R.; Merli, P.; Pigazzi, M.; Pession, A.; Locatelli, F.; Basso, G.

Influence of cranial radiotherapy on outcome in children with acute lymphoblastic leukemia treated with contemporary therapy

2016 - JOURNAL OF CLINICAL ONCOLOGY

Vora, A.; Andreano, A.; Pui, C. -H.; Hunger, S. P.; Schrappe, M.; Moericke, A.; Biondi, A.; Escherich, G.; Silverman, L. B.; Goulden, N.; Taskinen, M.; Pieters, R.; Horibe, K.; Devidas, M.; Locatelli, F.; Valsecchi, M. G.

KRAS and CREBBP mutations: a relapse-linked malicious liaison in childhood high hyperdiploid acute lymphoblastic leukemia

2015 - LEUKEMIA

Malinowska-Ozdowy, K.; Frech, C.; Schonegger, A.; Eckert, C.; Cazzaniga, G.; Stanulla, M.; Zur Stadt, U.; Mecklenbrauker, A.; Schuster, M.; Kneidinger, D.; Von Stackelberg, A.; Locatelli, F.; Schrappe, M.; Horstmann, M. A.; Attarbaschi, A.; Bock, C.; Mann, G.; Haas, O. A.; Panzer-Grumayer, R.

Collaborative efforts driving progress in pediatric acute myeloid leukemia

2015 - JOURNAL OF CLINICAL ONCOLOGY

Zwaan, Cm; Kolb, Ea; Reinhardt, D; Abrahamsson, J; Adachi, S; Aplenc, R; De Bont, Es; De Moerloose, B; Dworzak, M; Gibson, Be; Hasle, H; Leverger, G; Locatelli, F; Ragu, C; Ribeiro, Rc; Rizzari, C; Rubnitz, Je; Smith, Op; Sung, L; Tomizawa, D; van den Heuvel-Eibrink, Mm; Creutzig, U; Kaspers, Gj